ASE 2022 - 7 sessions on cardiac imaging to get excited about

The American Society of Echocardiography (ASE) is hosting its 33rd annual Scientific Sessions event, which brings together scientists, exhibitors, and medical professionals from across the globe to discuss the latest information in diagnosis and management of all aspects of cardiovascular disease. [1]

We at Ultromics are excited to announce that we’ll not only be exhibiting at the event, but we’ll be hosting our own S&T session which focuses on AI in cardiac imaging. You can learn more about it below.

ASE 2022 is a hybrid event that will take place both online and in Seattle, WA from June 10th to June 13th. [2] It features dozens of informative sessions and workshops on cardiac imaging. With so much to do in limited time, we have narrowed down the top seven sessions to look forward to this year:

1. What’s To Gain From Strain

Friday, June 10th / 2 – 3.30pm

Strain imaging techniques have shown great promise in supporting detection of early signs of cardiovascular disease, but how does it compare to ejection fraction? This session will take a deep dive into the benefits of strain imaging, while also taking into account its limitations. [3]

We definitely recommend coming to this session if you’re looking into ways to increase reporting accuracy.

2. Learning Lab: Basic Myocardial Strain Imaging (LV, RV,LA)

Saturday, June 11th / 12-2pm (basic) and 2:30-4:30pm (advanced)

This in-person course allows attendees to get practical experience in proper acquisition techniques and analysis of myocardial strain. The lab is offered at two separate times in the afternoon, based on experience level (basic or advanced). Participants will have access to ticketed computer-based learning labs as they analyze real cases on their own computer workstations.

The labs are overseen by experts in the field, but they do have limited capacity, so make sure to sign up as soon as possible.

3. AI: Revolutionizing the Diagnosis of Heart Disease in Echo

Sunday June 12th / 2pm – 2.45 pm

Ultromics is excited to announce that we will be hosting this session, which uncovers the latest studies and advances in AI for echocardiography.

As well as sharing experiences with using Ultromics’ AI-powered solutions for echocardiography analysis, attendees will have the chance to listen to three leaders in the field of echocardiography: Dr. Patricia A. Pellikka, Vice Chair, Department of Cardiovascular Medicine at Mayo Clinic, and Dr. Federico M. Asch, Director of the Echocardiography Core Lab at MedStar Health Research Institute, Georgetown University.

Pellikka will discuss the utilization of deep-learning applications to echocardiography for the diagnostic classification of cardiovascular disease. Additionally, Federico Asch, M.D. will discuss the latest results of the WASE-COVID study which compared human vs. machine learning-based echocardiography analysis and found AI was the best predictor of outcomes in acute Covid-19 patients. [4]

These speakers will be joined by Dr Ross Upton, CEO and Founder of Ultromics, who will showcase how Ultromics’ revolutionary AI solutions can help clinicians better detect and risk stratify heart disease, including offering attendees invaluable insights about the platform and implementation process.

4. Multimodality Imaging in Cardiomyopathy

Sunday June 12th / 3.30pm – 5pm

Accurate and rapid diagnosis for cardiomyopathies such as cardiac amyloidosis (CA) is essential to ensure initiation of therapeutic interventions that may slow or potentially prevent morbidity and mortality. [5] It’s important to get an understanding of different applications, their potential shortcomings, and how certain imaging modalities might affect treatment planning.

This session will detail multimodality imaging techniques used to detect cardiomyopathies, such as echocardiography, magnetic resonance imaging, and nuclear scanning modalities.

5. Global Artificial Intelligence – ASE/EACVI joint session

Monday June 13th / 2pm – 3.30 pm

As increasing evidence points toward AI revolutionizing cardiovascular imaging in the near future, the EACVI and the American Society of Echocardiography (ASE) has decided to host a joint session focusing on AI for heart disease detection.

Faculty and participants will come together to discuss how AI offers previously inconceivable new possibilities in the acquisition, workflow, and interpretation of images.

6. Great Debates: 3D, Artificial Intelligence, and Multimodality Imaging

Monday June 13th / 2pm – 3.30pm

The last day of the conferences ends with discussions about the future of digital technology. With the rapidly accelerating pace of development in AI and its integration into digital technology, all signs seem to indicate we are only a few years away from mass adoption of AI.

Speakers will debate this and the future of digital technology in this thought-provoking session.

7. Deploying Artificial Intelligence Systems in the Echo Lab

Monday June 13th / 4pm – 5.30pm

This fascinating session will cover the practical aspects of implementing AI in the lab. Discussion includes the importance of collecting large data repositories for AI algorithms and how, when this is achieved, how AI can improve accuracy in reporting.

As AI is already being integrated into many vendors’ systems to help speed workflow, this session will be extremely valuable for practitioners looking into new, innovative modalities. [6]

Connect with us at ASE 2022

ASE 2022 is looking to be an exciting event, with thought-provoking and educational sessions that will revolutionize the way we look at the diagnosis and management of cardiovascular disease.

Come meet the Ultromics team while you’re at the event!

References:

The American Society of Echocardiography : https://www.asecho.org/
ASE 2022 : https://www.asescientificsessions.org/
What’s to gain from strain Imaging [Internet]. www.ultromics.com. 2020
Karagodin I, Carvalho Singulane C, Woodward GM, et al. Echocardiographic Correlates of In-Hospital Death in Patients with Acute COVID-19 Infection: The World Alliance Societies of Echocardiography (WASE-COVID) Study. Journal of the American Society of Echocardiography. 2021;34:819–30.
Scheel PJ, Mukherjee M, Hays AG, et al. Multimodality Imaging in the Evaluation and Prognostication of Cardiac Amyloidosis. Frontiers in Cardiovascular Medicine. 2022;9.
D Fornell. Challenges to Implementing Artificial Intelligence in Cardiac Ultrasound [Internet]. DAIC. 2021.